Key result
Higher child polygenic risk score for HOMA-IR was significantly associated with a lower WIAT-III mean cognitive score at ~9 years (β = -0.222).
Why the study?
It is unclear whether the genetic burden of glycaemic dysregulation influences early-life neurodevelopment in metabolically susceptible Asian populations.
Does higher polygenic risk for glycaemic dysregulation reduce early-life cognitive development in children?
Cohort (n=1,095)
Yes
Does higher polygenic risk for glycaemic dysregulation reduce early-life cognitive development in children?
Higher child polygenic risk score for insulin resistance (HOMA-IR) is associated with lower cognitive scores in mid-childhood across both Asian and European cohorts.
Child PRS for HOMA-IR associates with lower cognitive scores; leaves open causality and ancestry effects pending trials.
Insulin resistance and glucose metabolism have been associated with neurodevelopmental disorders. However, in the metabolically more susceptible Asian populations, it is not clear whether the genetic burden of glycaemic dysregulation influences early-life neurodevelopment. In a multi-ethnic Asian prospective cohort study in Singapore (Growing Up in Singapore Towards healthy Outcomes (GUSTO)), we constructed child and parental polygenic risk scores (PRS) for glycaemic dysregulation based on the largest genome-wide association studies of type 2 diabetes and fasting glucose among Asians. We found that child PRS for HOMA-IR was associated with a lower perceptual reasoning score at ~7 years (β = -0. 141, p-value = 0.024, 95% CI -0. 264 to -0. 018) and a lower WIAT-III mean score at ~9 years (β = -0.222, p-value = 0.001, 95% CI -0.357 to -0.087). This association were consistent in direction among boys and girls. These inverse associations were not influenced by parental PRS and were likely mediated via insulin resistance rather than mediators such as birth weight and childhood body mass index. Higher paternal PRS for HOMA-IR was suggestively associated with lower child perceptual reasoning at ~7 years (β = -0.172, p-value = 0.002, 95% CI -0.280 to -0.064). Replication analysis in a European cohort, the Avon Longitudinal Study of Parents and Children (ALSPAC) birth cohort, showed that higher child PRS for fasting glucose was associated with lower verbal IQ score while higher maternal PRS for insulin resistance was associated with lower performance IQ score in their children at ~8.5 years. In summary, our findings suggest that higher child PRS for HOMA-IR was associated with lower cognitive scores in both Asian and European replication cohorts. Differential findings between cohorts may be attributed to genetic and environmental factors. Further investigation of the functions of the genetic structure and ancestry-specific PRS and a more comprehensive investigation of behavioural mediators may help to understand these findings better.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2024) conducted a cohort in Early-life cognitive development (n=1,095). Child polygenic risk score (PRS) for HOMA-IR vs. Lower polygenic risk score was evaluated on WIAT-III mean cognitive score at ~9 years (β = -0.222, 95% CI -0.357 to -0.087, p=0.001). Higher child polygenic risk score for HOMA-IR was significantly associated with a lower WIAT-III mean cognitive score at ~9 years (β = -0.222).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: